Tenecteplase Matches Alteplase in Safety and Effectiveness for Acute Ischemic Stroke, Study Finds Medha Baranwal23 March 2025 8:00 PM ISTUSA: A recent large-scale study evaluating real-world clinical data has found that tenecteplase is as effective and safe as alteplase for patients...
FDA Approves Tenecteplase as First Stroke Drug in Nearly 30 Years Dr. Kamal Kant Kohli5 March 2025 7:00 AM ISTThe US Food and Drug Administration has approved Tenecteplase as first FDA-approved stroke medication in nearly three decades. It offers a significant...
In ischaemic stroke, Tenecteplase tied to better recovery and reduced disability than alteplase: Study Dr. Kamal Kant Kohli18 Oct 2024 7:00 AM ISTFor people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent...
Tenecteplase Viable Alternative to Alteplase for Acute Ischemic Stroke in Chinese Patients, reports research Dr.Niharika Harsha B23 Sept 2024 9:15 PM ISTA recent innovative multicenter study conducted in China has found that tenecteplase, a bioengineered variant of alteplase, is noninferior with...
Improved Outcomes with Tenecteplase in Stroke Beyond 4.5 Hours: Study finds Dr. Garima Soni13 Aug 2024 6:00 AM ISTChina: Tenecteplase, has emerged as an effective thrombolytic agent when given 4.5 to 24 hours after the onset of stroke, a recent study reveals....
TASTE trial results support use of tenecteplase for acute ischaemic stroke within 4.5 hours based on perfusion imaging Dr. Kamal Kant Kohli28 May 2024 8:30 PM ISTIn the international TASTE trial, the intention-to- treat analysis narrowly failed to demonstrate non-inferiority of tenecteplase compared to...
Study Safety and Efficacy of Tenecteplase 0.25 mg/kg in Acute Ischemic Stroke: CDSCO Panel Tells Boehringer Ingelheim Dr. Divya Colin10 Feb 2024 6:00 PM ISTNew Delhi: Rejecting the drug major Boehringer Ingelheim's request for waiver of the local clinical trial of Metalyse 25 mg (tenecteplase 0.25 mg/kg)...
Study supports thrombolysis with tenecteplase in patients with ischemic stroke Medha Baranwal4 Jun 2023 8:00 PM ISTUSA: Stroke thrombolysis with tenecteplase is associated with lower odds of symptomatic intracranial haemorrhage (sICH) than treatment with alteplase,...
Tenecteplase fails to improve functional outcomes in wake-up stroke patients selected using non-contrast CT Jacinthlyn Sylvia20 Feb 2023 9:45 AM ISTMelinda Roaldsen and peers found that intravenous tenecteplase given within 4·5 hours of awakening does not improves any functional outcome in...
Hetero Biopharma gets CDSCO panel nod to market, manufacture Tenecteplase Susmita Roy29 Dec 2022 5:43 PM ISTNew Delhi: Pharma major Hetero Biopharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
Medical Bulletin 26/September/2022 Isra Zaman26 Sept 2022 4:46 PM ISTHere are the top medical news for the day:Transition to newer clot-busting drug improves patient outcomes and lowers treatment costA newer-generation...
Transition to newer clot-busting drug improves patient outcomes and lowers treatment cost Isra Zaman26 Sept 2022 9:00 AM ISTA newer-generation clot-busting drug called Tenecteplase outperforms the traditional treatment for ischemic strokes in several key areas, including...
